** Shares of specialty pharma co Assertio Holdings Inc
ASRT.O up 2.9% at $3.2 premarket
** Co raises its full-year 2022 forecast for net product
sales to over $152 mln, up from prior guidance of over $141 mln
** ASRT says it noted net product sales to date in Q4 have
significantly exceeded its prior expectations; co in November
posted a 32% y-o-y rise in Q3 net product sales
** Drugmaker posted Q3 revenue of $34.2 mln above analysts'
expectations of $31.3 mln for the quarter - Refinitiv IBES
** As of last close, ASRT up 40.4% YTD
(Reporting by Pratik Jain in Bengaluru)
((Pratik.Jain@thomsonreuters.com;))